The Kymriah (tisagenlecleucel) treatment has received a positive appraisal from the Scottish Medicines Consortium, after EMA approval last year.
List view / Grid view
diffuse large B-cell lymphoma (DLBCL)
Filter the results
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...